Silver Book Fact

The use of ACE inhibitors in hypertensive patients 80 years of older was associated in this study with a 30% reduction in the rate of stroke and a 64% reduction in the rate of heart failure. Additionally, these patients had 39% fewer fatal strokes, a 23% lower rate of cardiovascular events, and 21% fewer deaths from all causes.

Beckett N, Peters R, Fletcher A, Staessen J, et al. Treatment of Hypertension in Patients 80 Years of Age or Older. NEJM. 2008; 358(18): 1887-98. http://content.nejm.org/cgi/content/short/NEJMoa0801369

Reference

Title
Treatment of Hypertension in Patients 80 Years of Age or Older
Publication
NEJM
Publication Date
2008
Authors
Beckett N, Peters R, Fletcher A, Staessen J, et al
Volume & Issue
Volume 358, Issue 18
Pages
1887-98
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Stroke risk reduction from thrombin inhibitor in AFib patients
    A recently approved direct thrombin inhibitor was found to reduce the risk of stroke/peripheral embolic events in atrial fibrillation patients by 34%, and the risk of hemorrhagic stroke by 74%—compared…  
  • Antihypertensive Medicines Have Prevented Deaths and Hospitalizations: Study quantified impact of high blood pressure drugs on the U.S. population 1999-2000  
  • Satisfaction rates of heart valve disease patients with their treatment
     
  • 5 years of treatment with beta-blockers for heart failure increases patient survival by about 3 1/2 months and patients had fewer overnight hospital stays.  
  • Per-patient annual cost of treating stroke in atrial fibrillation patients
    The per-patient annual cost of treating stroke in atrial fibrillation patients was found to be $1,485 in a wellcontrolled anti-coagulation clinic, $3,710 for those receiving warfarin in routine medical care,…